img

Global Alpha L-Iduronidase Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Alpha L-Iduronidase Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Alpha L-Iduronidase Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Alpha L-Iduronidase industry at home and abroad, estimate the overall market scale of the Alpha L-Iduronidase industry and the market share of major countries, Alpha L-Iduronidase industry, and study and judge the downstream market demand of Alpha L-Iduronidase through systematic research, Analyze the competition pattern of Alpha L-Iduronidase, so as to help solve the pain points of various stakeholders in Alpha L-Iduronidase industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Alpha L-Iduronidase Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Alpha L-Iduronidase Market?
ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc
Major Type of Alpha L-Iduronidase Covered in XYZResearch report
IDUA
EC 3.2.1.76
Application Segments Covered in XYZResearch Market
Oncology
Dermatology
Immunology
Musculoskeletal Disorders

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Alpha L-Iduronidase Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Alpha L-Iduronidase Market by Value
2.2.1 Global Alpha L-Iduronidase Revenue by Type
2.2.2 Global Alpha L-Iduronidase Market by Value (%)
2.3 Global Alpha L-Iduronidase Market by Production
2.3.1 Global Alpha L-Iduronidase Production by Type
2.3.2 Global Alpha L-Iduronidase Market by Production (%)

3. The Major Driver of Alpha L-Iduronidase Industry
3.1 Historical & Forecast Global Alpha L-Iduronidase Demand
3.2 Largest Application for Alpha L-Iduronidase (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Alpha L-Iduronidase Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Alpha L-Iduronidase Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Alpha L-Iduronidase Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Alpha L-Iduronidase Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Alpha L-Iduronidase Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Alpha L-Iduronidase Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Alpha L-Iduronidase Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Alpha L-Iduronidase Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Alpha L-Iduronidase Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Alpha L-Iduronidase Average Price Trend
12.1 Market Price for Each Type of Alpha L-Iduronidase in US (2018-2022)
12.2 Market Price for Each Type of Alpha L-Iduronidase in Europe (2018-2022)
12.3 Market Price for Each Type of Alpha L-Iduronidase in China (2018-2022)
12.4 Market Price for Each Type of Alpha L-Iduronidase in Japan (2018-2022)
12.5 Market Price for Each Type of Alpha L-Iduronidase in India (2018-2022)
12.6 Market Price for Each Type of Alpha L-Iduronidase in Korea (2018-2022)
12.7 Market Price for Each Type of Alpha L-Iduronidase in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Alpha L-Iduronidase Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Alpha L-Iduronidase

14. Alpha L-Iduronidase Competitive Landscape
14.1 ArmaGen Inc
14.1.1 ArmaGen Inc Company Profiles
14.1.2 ArmaGen Inc Product Introduction
14.1.3 ArmaGen Inc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 BioStrategies LC
14.2.1 BioStrategies LC Company Profiles
14.2.2 BioStrategies LC Product Introduction
14.2.3 BioStrategies LC Alpha L-Iduronidase Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Denali Therapeutics Inc
14.3.1 Denali Therapeutics Inc Company Profiles
14.3.2 Denali Therapeutics Inc Product Introduction
14.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 EdiGene Inc
14.4.1 EdiGene Inc Company Profiles
14.4.2 EdiGene Inc Product Introduction
14.4.3 EdiGene Inc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Gain Therapeutics Inc
14.5.1 Gain Therapeutics Inc Company Profiles
14.5.2 Gain Therapeutics Inc Product Introduction
14.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Immusoft Corp
14.6.1 Immusoft Corp Company Profiles
14.6.2 Immusoft Corp Product Introduction
14.6.3 Immusoft Corp Alpha L-Iduronidase Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 JCR Pharmaceuticals Co Ltd
14.7.1 JCR Pharmaceuticals Co Ltd Company Profiles
14.7.2 JCR Pharmaceuticals Co Ltd Product Introduction
14.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Orchard Therapeutics Plc
14.8.1 Orchard Therapeutics Plc Company Profiles
14.8.2 Orchard Therapeutics Plc Product Introduction
14.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Ossianix Inc
14.9.1 Ossianix Inc Company Profiles
14.9.2 Ossianix Inc Product Introduction
14.9.3 Ossianix Inc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Rain Bio Inc
14.10.1 Rain Bio Inc Company Profiles
14.10.2 Rain Bio Inc Product Introduction
14.10.3 Rain Bio Inc Alpha L-Iduronidase Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 RegenxBio Inc
14.12 Tega Therapeutics Inc
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Alpha L-Iduronidase Industry (Volume)
Figure 2. Alpha L-Iduronidase Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Alpha L-Iduronidase Revenue in 2022
Figure 5. US Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Alpha L-Iduronidase Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Alpha L-Iduronidase Revenue, by Type (Million USD) (2018-2028)
Table 4. Alpha L-Iduronidase Production, by Type (K Unit) (2018-2028)
Table 5. Alpha L-Iduronidase Demand (K Unit) by Application (2018-2028)
Table 6. Alpha L-Iduronidase Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Alpha L-Iduronidase Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Alpha L-Iduronidase Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Alpha L-Iduronidase in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. ArmaGen Inc Profiles
Table 61. ArmaGen Inc Alpha L-Iduronidase Product Introduction
Table 62. ArmaGen Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. ArmaGen Inc Strategic initiatives
Table 64. BioStrategies LC Profiles
Table 65. BioStrategies LC Alpha L-Iduronidase Product Introduction
Table 66. BioStrategies LC Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. BioStrategies LC Strategic initiatives
Table 68. Denali Therapeutics Inc Profiles
Table 69. Denali Therapeutics Inc Alpha L-Iduronidase Product Introduction
Table 70. Denali Therapeutics Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Denali Therapeutics Inc Strategic initiatives
Table 72. EdiGene Inc Profiles
Table 73. EdiGene Inc Alpha L-Iduronidase Product Introduction
Table 74. EdiGene Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. EdiGene Inc Strategic initiatives
Table 76. Gain Therapeutics Inc Profiles
Table 77. Gain Therapeutics Inc Alpha L-Iduronidase Product Introduction
Table 78. Gain Therapeutics Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Gain Therapeutics Inc Strategic initiatives
Table 80. Immusoft Corp Profiles
Table 81. Immusoft Corp Alpha L-Iduronidase Product Introduction
Table 82. Immusoft Corp Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Immusoft Corp Strategic initiatives
Table 84. JCR Pharmaceuticals Co Ltd Profiles
Table 85. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Introduction
Table 86. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. JCR Pharmaceuticals Co Ltd Strategic initiatives
Table 88. Orchard Therapeutics Plc Profiles
Table 89. Orchard Therapeutics Plc Alpha L-Iduronidase Product Introduction
Table 90. Orchard Therapeutics Plc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Orchard Therapeutics Plc Strategic initiatives
Table 92. Ossianix Inc Profiles
Table 93. Ossianix Inc Alpha L-Iduronidase Product Introduction
Table 94. Ossianix Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Ossianix Inc Strategic initiatives
Table 97. Rain Bio Inc Profiles
Table 98. Rain Bio Inc Alpha L-Iduronidase Product Introduction
Table 99. Rain Bio Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Rain Bio Inc Strategic initiatives
Table 101. RegenxBio Inc Profiles
Table 102. RegenxBio Inc Alpha L-Iduronidase Product Introduction
Table 103. RegenxBio Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. RegenxBio Inc Strategic initiatives
Table 105. Tega Therapeutics Inc Profiles
Table 106. Tega Therapeutics Inc Alpha L-Iduronidase Product Introduction
Table 107. Tega Therapeutics Inc Alpha L-Iduronidase Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Tega Therapeutics Inc Strategic initiatives